ID   S22A2_RAT               Reviewed;         555 AA.
AC   Q9R0W2; P70485; P97558;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JUL-2024, entry version 144.
DE   RecName: Full=Solute carrier family 22 member 2 {ECO:0000303|PubMed:18180268};
DE   AltName: Full=Organic cation transporter 2 {ECO:0000303|PubMed:9812985};
DE            Short=rOCT2 {ECO:0000303|PubMed:9260930};
GN   Name=Slc22a2 {ECO:0000312|RGD:61936}; Synonyms=Oct2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND MISCELLANEOUS.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8702418; DOI=10.1006/bbrc.1996.1056;
RA   Okuda M., Saito H., Urakami Y., Takano M., Inui K.;
RT   "cDNA cloning and functional expression of a novel rat kidney organic
RT   cation transporter, OCT2.";
RL   Biochem. Biophys. Res. Commun. 224:500-507(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MISCELLANEOUS.
RC   TISSUE=Kidney cortex;
RX   PubMed=9260930; DOI=10.1089/dna.1997.16.871;
RA   Gorboulev V., Ulzheimer J.C., Akhoundova A., Ulzheimer-Teuber I.,
RA   Karbach U., Quester S., Baumann C., Lang F., Busch A.E., Koepsell H.;
RT   "Cloning and characterization of two human polyspecific organic cation
RT   transporters.";
RL   DNA Cell Biol. 16:871-881(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=10385678; DOI=10.1124/mol.56.1.1;
RA   Gruendemann D., Liebich G., Kiefer N., Koster S., Schoemig E.;
RT   "Selective substrates for non-neuronal monoamine transporters.";
RL   Mol. Pharmacol. 56:1-10(1999).
RN   [4]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICAL PROPERTIES.
RX   PubMed=9812985; DOI=10.1074/jbc.273.47.30915;
RA   Grundemann D., Koster S., Kiefer N., Breidert T., Engelhardt M.,
RA   Spitzenberger F., Obermuller N., Schomig E.;
RT   "Transport of monoamine transmitters by the organic cation transporter type
RT   2, OCT2.";
RL   J. Biol. Chem. 273:30915-30920(1998).
RN   [5]
RP   TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9830022; DOI=10.1074/jbc.273.49.32776;
RA   Wu X., Kekuda R., Huang W., Fei Y.-J., Leibach F.H., Chen J., Conway S.J.,
RA   Ganapathy V.;
RT   "Identity of the organic cation transporter OCT3 as the extraneuronal
RT   monoamine transporter (uptake2) and evidence for the expression of the
RT   transporter in the brain.";
RL   J. Biol. Chem. 273:32776-32786(1998).
RN   [6]
RP   INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10812069; DOI=10.1016/s0014-5793(00)01525-8;
RA   Urakami Y., Okuda M., Saito H., Inui K.;
RT   "Hormonal regulation of organic cation transporter OCT2 expression in rat
RT   kidney.";
RL   FEBS Lett. 473:173-176(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=10889205; DOI=10.1074/jbc.m004645200;
RA   Budiman T., Bamberg E., Koepsell H., Nagel G.;
RT   "Mechanism of electrogenic cation transport by the cloned organic cation
RT   transporter 2 from rat.";
RL   J. Biol. Chem. 275:29413-29420(2000).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND MISCELLANEOUS.
RX   PubMed=11758759; DOI=10.1023/a:1013070128668;
RA   Urakami Y., Okuda M., Masuda S., Akazawa M., Saito H., Inui K.;
RT   "Distinct characteristics of organic cation transporters, OCT1 and OCT2, in
RT   the basolateral membrane of renal tubules.";
RL   Pharm. Res. 18:1528-1534(2001).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11083459; DOI=10.1007/s004180000186;
RA   Sugawara-Yokoo M., Urakami Y., Koyama H., Fujikura K., Masuda S., Saito H.,
RA   Naruse T., Inui K., Takata K.;
RT   "Differential localization of organic cation transporters rOCT1 and rOCT2
RT   in the basolateral membrane of rat kidney proximal tubules.";
RL   Histochem. Cell Biol. 114:175-180(2000).
RN   [10]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MISCELLANEOUS.
RX   PubMed=12538837; DOI=10.1124/jpet.102.044404;
RA   Grundemann D., Hahne C., Berkels R., Schomig E.;
RT   "Agmatine is efficiently transported by non-neuronal monoamine transporters
RT   extraneuronal monoamine transporter (EMT) and organic cation transporter 2
RT   (OCT2).";
RL   J. Pharmacol. Exp. Ther. 304:810-817(2003).
RN   [11]
RP   MISCELLANEOUS.
RX   PubMed=16242669; DOI=10.1016/j.bcp.2005.09.020;
RA   Yonezawa A., Masuda S., Nishihara K., Yano I., Katsura T., Inui K.;
RT   "Association between tubular toxicity of cisplatin and expression of
RT   organic cation transporter rOCT2 (Slc22a2) in the rat.";
RL   Biochem. Pharmacol. 70:1823-1831(2005).
RN   [12]
RP   TISSUE SPECIFICITY, AND MISCELLANEOUS.
RX   PubMed=16272756; DOI=10.2133/dmpk.20.379;
RA   Kimura N., Masuda S., Tanihara Y., Ueo H., Okuda M., Katsura T., Inui K.;
RT   "Metformin is a superior substrate for renal organic cation transporter
RT   OCT2 rather than hepatic OCT1.";
RL   Drug Metab. Pharmacokinet. 20:379-386(2005).
RN   [13]
RP   FUNCTION, AND MISCELLANEOUS.
RX   PubMed=16006492; DOI=10.1124/jpet.105.088104;
RA   Tahara H., Kusuhara H., Endou H., Koepsell H., Imaoka T., Fuse E.,
RA   Sugiyama Y.;
RT   "A species difference in the transport activities of H2 receptor
RT   antagonists by rat and human renal organic anion and cation transporters.";
RL   J. Pharmacol. Exp. Ther. 315:337-345(2005).
RN   [14]
RP   MUTAGENESIS OF CYS-451.
RX   PubMed=17567940; DOI=10.1152/ajprenal.00106.2007;
RA   Sturm A., Gorboulev V., Gorbunov D., Keller T., Volk C., Schmitt B.M.,
RA   Schlachtbauer P., Ciarimboli G., Koepsell H.;
RT   "Identification of cysteines in rat organic cation transporters rOCT1
RT   (C322, C451) and rOCT2 (C451) critical for transport activity and substrate
RT   affinity.";
RL   Am. J. Physiol. 293:F767-F779(2007).
RN   [15]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15817714; DOI=10.1165/rcmb.2004-0363oc;
RA   Lips K.S., Volk C., Schmitt B.M., Pfeil U., Arndt P., Miska D., Ermert L.,
RA   Kummer W., Koepsell H.;
RT   "Polyspecific cation transporters mediate luminal release of acetylcholine
RT   from bronchial epithelium.";
RL   Am. J. Respir. Cell Mol. Biol. 33:79-88(2005).
RN   [16]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE
RP   SPECIFICITY, AND MISCELLANEOUS.
RX   PubMed=16581093; DOI=10.1016/j.neuropharm.2006.01.005;
RA   Amphoux A., Vialou V., Drescher E., Bruess M., Mannoury La Cour C.,
RA   Rochat C., Millan M.J., Giros B., Boenisch H., Gautron S.;
RT   "Differential pharmacological in vitro properties of organic cation
RT   transporters and regional distribution in rat brain.";
RL   Neuropharmacology 50:941-952(2006).
RN   [17]
RP   MISCELLANEOUS.
RX   PubMed=17582384; DOI=10.1016/j.bcp.2007.03.004;
RA   Yokoo S., Yonezawa A., Masuda S., Fukatsu A., Katsura T., Inui K.;
RT   "Differential contribution of organic cation transporters, OCT2 and MATE1,
RT   in platinum agent-induced nephrotoxicity.";
RL   Biochem. Pharmacol. 74:477-487(2007).
RN   [18]
RP   INDUCTION BY ISCHEMIA, AND MISCEALLENOUS.
RX   PubMed=18180268; DOI=10.1124/dmd.107.019869;
RA   Matsuzaki T., Morisaki T., Sugimoto W., Yokoo K., Sato D., Nonoguchi H.,
RA   Tomita K., Terada T., Inui K., Hamada A., Saito H.;
RT   "Altered pharmacokinetics of cationic drugs caused by down-regulation of
RT   renal rat organic cation transporter 2 (slc22a2) and rat multidrug and
RT   toxin extrusion 1 (slc47a1) in ischemia/reperfusion-induced acute kidney
RT   injury.";
RL   Drug Metab. Dispos. 36:649-654(2008).
CC   -!- FUNCTION: Electrogenic voltage-dependent transporter that mediates the
CC       transport of a variety of organic cations such as endogenous bioactive
CC       amines, cationic drugs and xenobiotics (PubMed:10889205,
CC       PubMed:12538837, PubMed:15817714, PubMed:16581093, PubMed:9812985).
CC       Functions as a Na(+)-independent, bidirectional uniporter (By
CC       similarity). Cation cellular uptake or release is driven by the
CC       electrochemical potential, i.e. membrane potential and concentration
CC       gradient (PubMed:10889205). However, may also engage electroneutral
CC       cation exchange when saturating concentrations of cation substrates are
CC       reached (PubMed:10889205). Predominantly expressed at the basolateral
CC       membrane of hepatocytes and proximal tubules and involved in the uptake
CC       and disposition of cationic compounds by hepatic and renal clearance
CC       from the blood flow (By similarity). Implicated in monoamine
CC       neurotransmitters uptake such as histamine, dopamine,
CC       adrenaline/epinephrine, noradrenaline/norepinephrine, serotonin and
CC       tyramine, thereby supporting a physiological role in the central
CC       nervous system by regulating interstitial concentrations of
CC       neurotransmitters (PubMed:16581093, PubMed:9812985). Also capable of
CC       transporting dopaminergic neuromodulators cyclo(his-pro), salsolinol
CC       and N-methyl-salsolinol, thereby involved in the maintenance of
CC       dopaminergic cell integrity in the central nervous system (By
CC       similarity). Mediates the bidirectional transport of acetylcholine
CC       (ACh) at the apical membrane of ciliated cell in airway epithelium,
CC       thereby playing a role in luminal release of ACh from bronchial
CC       epithelium (PubMed:15817714). Also transports guanidine and endogenous
CC       monoamines such as vitamin B1/thiamine, creatinine and N-1-
CC       methylnicotinamide (NMN) (PubMed:11758759). Mediates the uptake and
CC       efflux of quaternary ammonium compound choline (PubMed:10889205).
CC       Mediates the bidirectional transport of polyamine agmatine and the
CC       uptake of polyamine putrescine (PubMed:12538837). Able to transport
CC       non-amine endogenous compounds such as prostaglandin E2 (PGE2) and
CC       prostaglandin F2-alpha (PGF2-alpha) (By similarity). Also involved in
CC       the uptake of xenobiotic 4-(4-(dimethylamino)styryl)-N-methylpyridinium
CC       (ASP) (By similarity). May contribute to regulate the transport of
CC       organic compounds in testis across the blood-testis-barrier (By
CC       similarity). {ECO:0000250|UniProtKB:O15244,
CC       ECO:0000269|PubMed:10889205, ECO:0000269|PubMed:11758759,
CC       ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15817714,
CC       ECO:0000269|PubMed:16581093, ECO:0000269|PubMed:9812985}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-noradrenaline(out) = (R)-noradrenaline(in);
CC         Xref=Rhea:RHEA:73871, ChEBI:CHEBI:72587;
CC         Evidence={ECO:0000269|PubMed:16581093, ECO:0000269|PubMed:9812985};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-adrenaline(out) = (R)-adrenaline(in);
CC         Xref=Rhea:RHEA:73875, ChEBI:CHEBI:71406;
CC         Evidence={ECO:0000269|PubMed:16581093, ECO:0000269|PubMed:9812985};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=serotonin(out) = serotonin(in); Xref=Rhea:RHEA:73867,
CC         ChEBI:CHEBI:350546; Evidence={ECO:0000269|PubMed:16581093,
CC         ECO:0000269|PubMed:9812985};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dopamine(out) = dopamine(in); Xref=Rhea:RHEA:73863,
CC         ChEBI:CHEBI:59905; Evidence={ECO:0000269|PubMed:16581093,
CC         ECO:0000269|PubMed:9812985};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=histamine(out) = histamine(in); Xref=Rhea:RHEA:73879,
CC         ChEBI:CHEBI:58432; Evidence={ECO:0000269|PubMed:16581093};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=thiamine(in) = thiamine(out); Xref=Rhea:RHEA:34919,
CC         ChEBI:CHEBI:18385; Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=creatinine(in) = creatinine(out); Xref=Rhea:RHEA:74539,
CC         ChEBI:CHEBI:16737; Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-methylnicotinamide(out) = 1-methylnicotinamide(in);
CC         Xref=Rhea:RHEA:73859, ChEBI:CHEBI:16797;
CC         Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanidine(out) = guanidine(in); Xref=Rhea:RHEA:73883,
CC         ChEBI:CHEBI:30087; Evidence={ECO:0000269|PubMed:11758759};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=choline(out) = choline(in); Xref=Rhea:RHEA:32751,
CC         ChEBI:CHEBI:15354; Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=agmatine(out) = agmatine(in); Xref=Rhea:RHEA:72131,
CC         ChEBI:CHEBI:58145; Evidence={ECO:0000269|PubMed:12538837};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:72132;
CC         Evidence={ECO:0000250|UniProtKB:O15244};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:72133;
CC         Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=putrescine(out) = putrescine(in); Xref=Rhea:RHEA:72135,
CC         ChEBI:CHEBI:326268; Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=spermidine(in) = spermidine(out); Xref=Rhea:RHEA:35039,
CC         ChEBI:CHEBI:57834; Evidence={ECO:0000250|UniProtKB:O70577};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tyramine(in) = tyramine(out); Xref=Rhea:RHEA:74783,
CC         ChEBI:CHEBI:327995; Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-histidyl-L-proline diketopiperazine(in) = L-histidyl-L-
CC         proline diketopiperazine(out); Xref=Rhea:RHEA:74787,
CC         ChEBI:CHEBI:90039; Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-salsolinol(in) = (R)-salsolinol(out);
CC         Xref=Rhea:RHEA:74791, ChEBI:CHEBI:194082;
CC         Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-methyl-(R)-salsolinol(in) = N-methyl-(R)-salsolinol(out);
CC         Xref=Rhea:RHEA:74795, ChEBI:CHEBI:194083;
CC         Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetylcholine(in) = acetylcholine(out); Xref=Rhea:RHEA:74663,
CC         ChEBI:CHEBI:15355; Evidence={ECO:0000269|PubMed:15817714};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prostaglandin F2alpha(out) = prostaglandin F2alpha(in);
CC         Xref=Rhea:RHEA:50988, ChEBI:CHEBI:57404;
CC         Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prostaglandin E2(out) = prostaglandin E2(in);
CC         Xref=Rhea:RHEA:50984, ChEBI:CHEBI:606564;
CC         Evidence={ECO:0000250|UniProtKB:O15244};
CC   -!- ACTIVITY REGULATION: Tyrosine phosphorylation of the transporter leads
CC       to activation of the transport activity. Inhibited by cGMP, most likely
CC       through a cGMP-binding protein that interacts with OCT2.
CC       {ECO:0000250|UniProtKB:O15244}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.76 mM for serotonin {ECO:0000269|PubMed:16581093};
CC         KM=3.6 mM for serotonin {ECO:0000269|PubMed:9812985};
CC         KM=0.89 mM for histamine {ECO:0000269|PubMed:16581093};
CC         KM=0.95 mM for agmatine (at pH 7.4) {ECO:0000269|PubMed:12538837};
CC         KM=1.37 mM for adrenaline {ECO:0000269|PubMed:16581093};
CC         KM=1.9 mM for adrenaline {ECO:0000269|PubMed:9812985};
CC         KM=2.1 mM for dopamine {ECO:0000269|PubMed:16581093,
CC         ECO:0000269|PubMed:9812985};
CC         KM=2.1 mM for noradrenaline {ECO:0000269|PubMed:16581093};
CC         KM=4.4 mM for noradrenaline {ECO:0000269|PubMed:9812985};
CC         Vmax=9900 pmol/min/mg enzyme for agmatine uptake (at pH 7.4)
CC         {ECO:0000269|PubMed:12538837};
CC         Vmax=590 pmol/min/mg enzyme for adrenaline uptake
CC         {ECO:0000269|PubMed:9812985};
CC         Vmax=3900 pmol/min/mg enzyme for dopamine uptake
CC         {ECO:0000269|PubMed:9812985};
CC         Vmax=2500 pmol/min/mg enzyme for serotonin uptake
CC         {ECO:0000269|PubMed:9812985};
CC         Vmax=1000 pmol/min/mg enzyme for noradrenaline uptake
CC         {ECO:0000269|PubMed:9812985};
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:11083459}; Multi-pass membrane protein
CC       {ECO:0000305}. Basal cell membrane {ECO:0000250|UniProtKB:O15244};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:O15244}. Apical cell
CC       membrane {ECO:0000269|PubMed:15817714}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=Localized to the basolateral membranes of renal
CC       proximal tubular cells (PubMed:11083459). Localized to the
CC       luminal/apical membrane of ciliated epithelial cells in the airway
CC       (PubMed:15817714). {ECO:0000269|PubMed:11083459,
CC       ECO:0000269|PubMed:15817714}.
CC   -!- TISSUE SPECIFICITY: Expressed in the kidney, in the proximal tubules of
CC       cortex and of the outer medulla (PubMed:10812069, PubMed:11083459,
CC       PubMed:11758759, PubMed:16272756, PubMed:8702418, PubMed:9830022). In
CC       brain, highly expressed predominantly in regions located at the brain-
CC       cerebrospinal fluid border, in the leptomeninges, in the choroid plexus
CC       and in a layer boarding the third ventricle. In brain, also observed in
CC       the granular cell layer of the cerebellum and in the granular layer and
CC       pyramidal cells of the hippocampus in the CA1-CA3 regions
CC       (PubMed:16581093). Expressed in tracheal and bronchial ciliated
CC       epithelium in the respiratory tract (PubMed:15817714). Expression is
CC       greater in the kidney of male than of female (PubMed:16272756).
CC       {ECO:0000269|PubMed:10812069, ECO:0000269|PubMed:11083459,
CC       ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:15817714,
CC       ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16581093,
CC       ECO:0000269|PubMed:8702418}.
CC   -!- INDUCTION: Down-regulated in ischemia/reperfusion (I/R) kidneys
CC       (PubMed:18180268). Up-regulated by testosterone and moderately down-
CC       regulated by estradiol (PubMed:10812069). {ECO:0000269|PubMed:10812069,
CC       ECO:0000269|PubMed:18180268}.
CC   -!- DOMAIN: Contains one proline-rich sequence (Pro-Glu-Ser-Pro-Arg) that
CC       may be involved in tyrosine-protein kinase YES1 binding and is required
CC       for the activation of substrate transport.
CC       {ECO:0000250|UniProtKB:O15244}.
CC   -!- PTM: Tyrosine phosphorylated. {ECO:0000250|UniProtKB:O15244}.
CC   -!- MISCELLANEOUS: Mediates the renal secretion of many clinically used
CC       cationic drugs (Probable) (PubMed:16272756). Transports drugs such as
CC       diabetes treatment medicine metformin and neurotoxins 1-methyl-4-
CC       phenylpyridinium (MPP(+)), famotidine, ranitidine, amantadine,
CC       acriflavine, amiloride, memantine, cimetidine, cisplatin, oxaliplatin,
CC       platinum-based drugs cisplatin and oxaliplatin, 3'-azido-3'-
CC       deoxythymidine (AZT) and tetraethylammonium (TEA) (PubMed:11758759,
CC       PubMed:12538837, PubMed:16006492, PubMed:16242669, PubMed:16272756,
CC       PubMed:16581093, PubMed:8702418). Mediates the bidirectional transport
CC       of MPP(+) (PubMed:9260930). Metformin competitively inhibits OCT1-
CC       mediated thiamine uptake, leading to a decrease in hepatic steatosis
CC       (By similarity). Plays a predominant role in the anticancer activity of
CC       cisplatin and oxaliplatin and may contribute to antitumor specificity
CC       (PubMed:17582384). Involved in cisplatin-induced nephrotoxicity
CC       (PubMed:16242669, PubMed:17582384). {ECO:0000250|UniProtKB:O15244,
CC       ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12538837,
CC       ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16242669,
CC       ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16581093,
CC       ECO:0000269|PubMed:17582384, ECO:0000269|PubMed:8702418,
CC       ECO:0000269|PubMed:9260930, ECO:0000303|PubMed:16272756,
CC       ECO:0000305|PubMed:18180268}.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1) superfamily.
CC       Organic cation transporter (TC 2.A.1.19) family. {ECO:0000305}.
CC   -!- CAUTION: While most authors have deduced a localization at the
CC       basolateral membrane of proximal tubules, other studies demonstrated a
CC       localization to the luminal membrane in the distal tubule.
CC       {ECO:0000250|UniProtKB:O15244}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA11754.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA66979.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D83044; BAA11754.1; ALT_FRAME; mRNA.
DR   EMBL; X98334; CAA66979.1; ALT_FRAME; mRNA.
DR   EMBL; Y13154; CAB52215.1; -; mRNA.
DR   PIR; JC4884; JC4884.
DR   RefSeq; NP_113772.1; NM_031584.2.
DR   AlphaFoldDB; Q9R0W2; -.
DR   SMR; Q9R0W2; -.
DR   STRING; 10116.ENSRNOP00000023116; -.
DR   BindingDB; Q9R0W2; -.
DR   ChEMBL; CHEMBL1770032; -.
DR   TCDB; 2.A.1.19.19; the major facilitator superfamily (mfs).
DR   GlyCosmos; Q9R0W2; 1 site, No reported glycans.
DR   GlyGen; Q9R0W2; 1 site.
DR   iPTMnet; Q9R0W2; -.
DR   PhosphoSitePlus; Q9R0W2; -.
DR   PaxDb; 10116-ENSRNOP00000023116; -.
DR   GeneID; 29503; -.
DR   KEGG; rno:29503; -.
DR   AGR; RGD:61936; -.
DR   CTD; 6582; -.
DR   RGD; 61936; Slc22a2.
DR   eggNOG; KOG0255; Eukaryota.
DR   InParanoid; Q9R0W2; -.
DR   OrthoDB; 1474205at2759; -.
DR   PhylomeDB; Q9R0W2; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-RNO-112311; Neurotransmitter clearance.
DR   Reactome; R-RNO-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-2161517; Abacavir transmembrane transport.
DR   Reactome; R-RNO-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   Reactome; R-RNO-549127; Organic cation transport.
DR   SABIO-RK; Q9R0W2; -.
DR   PRO; PR:Q9R0W2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098981; C:cholinergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0005277; F:acetylcholine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005275; F:amine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015220; F:choline transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0015562; F:efflux transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0061459; F:L-arginine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0008504; F:monoamine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005326; F:neurotransmitter transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015101; F:organic cation transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015132; F:prostaglandin transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015489; F:putrescine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015214; F:pyrimidine nucleoside transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015606; F:spermidine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005496; F:steroid binding; IDA:RGD.
DR   GO; GO:0015234; F:thiamine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0019534; F:toxin transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IMP:ARUK-UCL.
DR   GO; GO:0015870; P:acetylcholine transport; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:ARUK-UCL.
DR   GO; GO:0015837; P:amine transport; ISO:RGD.
DR   GO; GO:0089718; P:amino acid import across plasma membrane; ISO:RGD.
DR   GO; GO:1990748; P:cellular detoxification; IDA:ARUK-UCL.
DR   GO; GO:0015871; P:choline transport; ISO:RGD.
DR   GO; GO:0015872; P:dopamine transport; IDA:UniProtKB.
DR   GO; GO:0090494; P:dopamine uptake; ISO:RGD.
DR   GO; GO:0048241; P:epinephrine transport; IDA:UniProtKB.
DR   GO; GO:0140115; P:export across plasma membrane; ISO:RGD.
DR   GO; GO:0051608; P:histamine transport; IDA:UniProtKB.
DR   GO; GO:0051615; P:histamine uptake; ISO:RGD.
DR   GO; GO:1902475; P:L-alpha-amino acid transmembrane transport; ISO:RGD.
DR   GO; GO:0097638; P:L-arginine import across plasma membrane; ISO:RGD.
DR   GO; GO:0006812; P:monoatomic cation transport; ISO:RGD.
DR   GO; GO:0006836; P:neurotransmitter transport; ISO:RGD.
DR   GO; GO:0015874; P:norepinephrine transport; IDA:UniProtKB.
DR   GO; GO:0051620; P:norepinephrine uptake; ISO:RGD.
DR   GO; GO:0015695; P:organic cation transport; IDA:ARUK-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0015732; P:prostaglandin transport; ISS:UniProtKB.
DR   GO; GO:0015847; P:putrescine transport; ISS:UniProtKB.
DR   GO; GO:0015697; P:quaternary ammonium group transport; IDA:RGD.
DR   GO; GO:0006837; P:serotonin transport; IDA:UniProtKB.
DR   GO; GO:0051610; P:serotonin uptake; ISO:RGD.
DR   GO; GO:0015848; P:spermidine transport; ISS:UniProtKB.
DR   GO; GO:0071934; P:thiamine transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0042908; P:xenobiotic transport; IDA:ARUK-UCL.
DR   GO; GO:1990962; P:xenobiotic transport across blood-brain barrier; NAS:ARUK-UCL.
DR   CDD; cd17379; MFS_SLC22A1_2_3; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004749; Orgcat_transp/SVOP.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   NCBIfam; TIGR00898; 2A0119; 1.
DR   PANTHER; PTHR24064; SOLUTE CARRIER FAMILY 22 MEMBER; 1.
DR   PANTHER; PTHR24064:SF432; SOLUTE CARRIER FAMILY 22 MEMBER 2; 1.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS50850; MFS; 1.
DR   PROSITE; PS00216; SUGAR_TRANSPORT_1; 2.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..555
FT                   /note="Solute carrier family 22 member 2"
FT                   /id="PRO_0000320962"
FT   TOPO_DOM        1..21
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        22..42
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        43..150
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        151..171
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        172..177
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        178..198
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        199..210
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        211..231
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        232..238
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        239..259
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        260..263
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        264..284
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        285..348
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        349..369
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        370..375
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        376..396
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        397..404
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        405..425
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        426..432
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        433..453
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        454..464
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        465..485
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        486..494
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        495..515
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        516..555
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOTIF           284..288
FT                   /note="Proline-rich sequence"
FT                   /evidence="ECO:0000250|UniProtKB:O15244"
FT   SITE            451
FT                   /note="Involved in recognition of organic cations and
FT                   participates in structural changes that occur during
FT                   translocation of organic cations"
FT                   /evidence="ECO:0000269|PubMed:17567940"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         451
FT                   /note="C->M: Transport activity strongly reduced."
FT                   /evidence="ECO:0000269|PubMed:17567940"
FT   CONFLICT        332
FT                   /note="N -> K (in Ref. 1; BAA11754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        335
FT                   /note="F -> I (in Ref. 1; BAA11754)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   555 AA;  62343 MW;  29521969AE1AC206 CRC64;
     MSTVDDILEH IGEFHLFQKQ TFFLLALLSG AFTPIYVGIV FLGFTPDHHC WSPGAAKLSQ
     RCGWSQAEEL NYTVPGLGPS DEASFLSQCM RYEVDWNQST LDCVDPLSSL AADRNQLPLG
     PCEHGWVYNT PGSSIVTEFN LVCAHSWMLD LFQSVVNVGF FIGAMMIGYL ADRFGRKFCL
     LVTILINAIS GALMAISPNY AWMLVFRFLQ GLVSKAGWLI GYILITEFVG LGYRRMVGIC
     YQIAFTVGLL ILAGVAYVIP NWRWLQFAVT LPNFCFLLYF WCIPESPRWL ISQNKIVKAM
     KIIKHIAKKN GKSVPVSLQN LTPDEDAGKK LNPSFLDLVR TPQIRKHTLI LMYNWFTSSV
     LYQGLIMHMG LAGDNIYLDF FYSALVEFPA AFIIILTIDR VGRRYPWAVS NMVAGAACLA
     SVFIPDDLQW LKITIACLGR MGITMAYEMV CLVNAELYPT YIRNLGVLVC SSMCDIGGII
     TPFLVYRLTD IWMEFPLVVF AVVGLVAGAL VLLLPETKGK ALPETIEDAE NMQRPRKKKE
     KRIYLQVKQA DRPLS
//
